
Monodose SB 250mg/125mg Injection
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Monodose SB 250mg/125mg Injection
This dual-strength injectable medication, SB 250mg/125mg Monodose, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional; consistent adherence to the prescribed regimen is crucial for effective treatment, even with symptom improvement. Premature cessation may compromise therapeutic efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require prompt emergency care. Prior to initiating treatment, disclose all current medications and pre-existing conditions to your physician. This is especially important for pregnant or lactating individuals. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration support optimal recovery. Your doctor might order lab tests to monitor the medication's impact.
Uses of Monodose SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Monodose SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monodose SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Monodose SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Monodose SB 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg (Monodose SB) injection unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Sulbactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of alcohol and Monodose SB 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Monodose SB 250mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
Administering the single-dose SB 250mg/125mg injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
A single dose of SB 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Monodose SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 250mg/125mg Monodose SB Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for this injection isn't suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Monodose SB 250mg/125mg Injection :
Should you forget a scheduled dose of Monodose SB 250mg/125mg Injection, seek medical advice.
Facts to Know About Monodose SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective Agents |
